Evaluation of the TEG(® )platelet mapping™ assay in blood donors

BACKGROUND: Monitoring of antiplatelet therapy in patients at cardiovascular risk is difficult because existing platelet function tests are too sophisticated for clinical routine. The whole blood TEG(® )Platelet Mapping™ assay measures clot strength as maximal amplitude (MA) and enables for quantifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bochsen, Louise, Wiinberg, Bo, Kjelgaard-Hansen, Mads, Steinbrüchel, Daniel A, Johansson, Pär I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804261/
https://www.ncbi.nlm.nih.gov/pubmed/17311677
http://dx.doi.org/10.1186/1477-9560-5-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804261/
https://www.ncbi.nlm.nih.gov/pubmed/17311677
http://dx.doi.org/10.1186/1477-9560-5-3

Ejemplares similares